Healthcare Strides latest gainer as investors chase pharma stocks on COVID cure hopes Updated : May 11, 2020 09:16 PM IST Last week, Glenmark shares were in the limelight after the company sought the Drug Controller General of India’s nod to start clinical trials for favipiravir. Cipla received approval from the US FDA for the generic version of inhaler Proventil HFA used for breathing or lung related conditions such as asthma. Still, pharma has been a clear outperformer in a volatile market ravaged by the COVID pandemic. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.